Company data
Precigen, Inc. employees and revenue per employee
PGEN · Biotechnology · $2.15B market cap
Precigen, Inc. had 160 employees at the end of fiscal Dec 2025, up 11.9% from a year earlier. Revenue for the year was $9.7M, up 146.7% from a year earlier, or $61K per employee. Revenue and headcount both grew, and revenue grew faster.
Employees
160
+11.9% YoY
Revenue
$9.7M
+146.7% YoY
Revenue / employee
$61K
Peer median $602K
Rank in industry
37 of 39
Biotechnology
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Dec 2025 | 160 | $9.7M | $61K | +11.9% | +146.7% |
| Dec 2024 | 143 | $3.9M | $27K | +6.7% | -36.9% |
| Dec 2023 | 134 | $6.2M | $46K | -35.9% | -76.9% |
| Dec 2022 | 209 | $26.9M | $129K | -21.1% | +88.6% |
| Dec 2021 | 265 | $14.3M | $54K | +15.7% | -55.4% |
| Dec 2020 | 229 | $32.0M | $140K | -70.3% | +0.0% |
| Dec 2019 | 770 | $32.0M | $42K | -12.7% | -80.1% |
| Dec 2018 | 882 | $161M | $182K | -2.6% | -30.5% |
| Dec 2017 | 906 | $231M | $255K | +8.9% | +21.0% |
| Dec 2016 | 832 | $191M | $229K | — | — |
Open roles: we have not matched a verified job board for this company yet.
Precigen, Inc. against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| AMLX Amylyx Pharmaceuticals, Inc. | 123 | $87.4M | $710K | Contracting |
| PTGX Protagonist Therapeutics, Inc. | 132 | $46.0M | $349K | Hiring into decline |
| NUVB Nuvation Bio Inc. | 298 | $62.9M | $211K | Efficient growth |
| KYMR Kymera Therapeutics, Inc. | 238 | $39.2M | $165K | Hiring into decline |
| RLAY Relay Therapeutics, Inc. | 192 | $15.4M | $80K | Leaner |
| PRAX Praxis Precision Medicines, Inc. | 116 | $8.6M | $74K | Efficient growth |
| PGEN Precigen, Inc. | 160 | $9.7M | $61K | Efficient growth |
| IMNM Immunome, Inc. | 177 | $6.9M | $39K | Hiring into decline |
| CRNX Crinetics Pharmaceuticals, Inc. | 594 | $7.7M | $13K | Efficient growth |
Questions about Precigen, Inc.
- How many employees does Precigen, Inc. have?
- Precigen, Inc. reported 160 employees for the fiscal year ending Dec 2025, in the annual report it filed on March 25, 2026. That is up 11.9% from a year earlier.
- What is Precigen, Inc.'s revenue per employee?
- Precigen, Inc. brought in $9.7M of revenue in fiscal Dec 2025, which is $61K per employee. That ranks 37 of 39 companies we track in Biotechnology, where the median is $602K.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare PGEN with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Precigen, Inc.'s annual reports (Form 10-K), latest filed March 25, 2026. This is data, not a recommendation to buy or sell PGEN.